The Economic Impact of Exacerbations of Chronic Obstructive Pulmonary Disease and Exacerbation Definition: A Review

REFERENCES

• Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007; 4:502–506.
   PubMedGoogle Scholar
• National Heart, Lung, and Blood Institute. Morbidity and Mortality: 2009 Chartbook on Cardiovascular, Lung and Blood Diseases. Retrieved from http://www.nhlbi.nih.gov/resources/docs/cht-book.htm. Bethesda, Maryland: US Department of Health and Human Services, Public Health Service, National Institute of Health.
   Google Scholar
• Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932–946.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J, Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003; 21:46s–53s.
   Google Scholar
• McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: A summary and appraisal of published evidence. Chest 2001; 119:1190–1209.
   PubMed Web of Science ®Google Scholar
• Simoens S, Decramer M, De Coster S, Celis G, Laekeman G. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations. Int J Clin Pract 2007; 61:200–206.
   PubMed Web of Science ®Google Scholar
• O’Reilly JF, Williams AE, Rice L. Health status impairment and costs associated with COPD exacerbation managed in hospital. Int J Clin Pract 2007; 61:1112–1120.
   PubMed Web of Science ®Google Scholar
• Jahnz-Różyk K, Targowski T, From S. Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland. Pol Pneumonol Allergol 2008; 76:426–431.
   PubMedGoogle Scholar
• Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, FitzGerald JM. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008;102:413–421.
   PubMed Web of Science ®Google Scholar
• Oostenbrink JB, Rutten-van Mölken, MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004; 98:883–891.
   PubMed Web of Science ®Google Scholar
• Andersson F, Borg S, Jansson SA, Jonsson AC, Ericsson Á, Prütz C, Rönmark E, Lundbäck B. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002; 96:700–708.
   PubMed Web of Science ®Google Scholar
• Price MJ, Hurrell C, Efthimiou J, Medley HV. Health care costs of treating exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J 1999; 14(Suppl 30):380s.
   Google Scholar
• Miravitlles M, Murio C, Guerrero T, Gisbert R. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121:1449–1455.
   PubMed Web of Science ®Google Scholar
• Llor C, Naberan K, Cots JM, Molina J, Miravitlles M. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care. Int J Clin Pract 2004; 58:937–944.
   PubMed Web of Science ®Google Scholar
• Schermer TRJ, Saris CGJ, Van Den Bosch WJHM, Chavannes NH, van Schayck CP, Dekhuijzen PNR, van Weel C. Exacerbations and associated healthcare cost in patients with COPD in general practice. Monaldi Arch Chest Dis 2006;65:133–140.
   PubMedGoogle Scholar
• Masa JF, Sobradillo V, Villasante C, Jiménez-Ruiz CA, Fernández-Fau L, Viejo JL, Miravitlles M. Costs of chronic obstructive pulmonary disease in spain: estimation from a population-based study. Arch Bronconeumol 2004;40:72–9.
   PubMed Web of Science ®Google Scholar
• Britton M. The burden of COPD in the UK: Results from the Confronting COPD survey. Respir Med 2003;97(Suppl C):S71–9.
   PubMed Web of Science ®Google Scholar
• Izquierdo JL. The burden of COPD in Spain: Results from the Confronting COPD survey. Respir Med 2003;97(Suppl C):S61–S69.
   PubMed Web of Science ®Google Scholar
• Buist AS, Vollmer WM, Sullivan SD, Weiss KB, Lee TA, Menezes AM, Crapo RO, Jensen RL, Burney PG. The burden of obstructive lung disease initiative (BOLD): rationale and design. COPD 2005; 2:277–283.
   PubMedGoogle Scholar
• Nielsen R, Johannessen A, Benediktsdottir B, Gislason T, Buist AS, Gulsvik A, Sullivan SD, Lee TA. Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J 2009; 34:850–857.
   PubMed Web of Science ®Google Scholar
• Aaron SD, Fergusson D, Marks GB, Suissa S, Vandemheen KL, Doucette S, Maltais F, Bourbeau JF, Goldstein RS, Balter M, O’Donnell D, Fitzgerald M. Counting, analysing and reporting exacerbations of COPD in randomized controlled trials. Thorax 2008; 63:122–128.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106:196–204.
   PubMed Web of Science ®Google Scholar
• Calverley P, Pauwels R, Löfdahl CG, Svensson K, Higenbottam T, Carlsson LG, Ståhl E. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005; 26:406–413.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Wedzicha JA. What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines. Thorax 2007; 62:198–199.
   PubMed Web of Science ®Google Scholar
• Jones P, Higenbottam T. Quantifying of severity of exacerbations in chronic obstructive pulmonary disease: adaptations to the definition to allow quantification. Proc Am Thorac Soc 2007; 4:597–601.
   PubMedGoogle Scholar
• Leidy NK, Wilcox TK, Roberts L, Winnette RM, Murray L, and the EXACT-PRO Study Group. The EXACT-PRO Initiative: Development and Validation of a Single Patient-Reported Outcome Measure for Evaluating Exacerbations of Chronic Obstructive Pulmonary Disease. Presented at the International Society for Pharmacoeconomics and Outcomes Research 11th Annual European Congress, November 8–11, 2008; Athens, Greece.
   Google Scholar
• EXACT-PRO Initiative, Retrieved January 11, 2010, from http://www.exactproinitiative.com.
   Google Scholar
• O’Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J 2006; 15:346–353.
   PubMedGoogle Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157:1418–1422.
   Google Scholar
• Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course of recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608–1613.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, MacCallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:1618–1623.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57:847–852.
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169:1298–1303.
   PubMed Web of Science ®Google Scholar
• Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med 2008; 177:396–401.
   PubMed Web of Science ®Google Scholar
• Vijayasaratha K, Stockley RA. Reported and unreported exacerbations of COPD: analysis by diary cards. Chest 2008; 133:34–41.
   PubMed Web of Science ®Google Scholar